Publications

Found 2 results
Filters: Author is A. Acharya  [Clear All Filters]
2010
P. N. Mukhopadhyaya, Acharya, A., Chavan, Y., Purohit, S. S., and Mutha, A., Metagenomic study of single-nucleotide polymorphism within candidate genes associated with type 2 diabetes in, vol. 9, pp. 2060-2068, 2010.
Akaike H (1974). A new look at the statistical model identification. IEEE Trans. Automat. Contr. 19: 716-723. http://dx.doi.org/10.1109/TAC.1974.1100705   Bennermo M, Held C, Stemme S, Ericsson CG, et al. (2004). Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin. Chem. 50: 2136-2140. http://dx.doi.org/10.1373/clinchem.2004.037531 PMid:15364891   Bid HK, Konwar R, Aggarwal CG, Gautam S, et al. (2009). Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J. Med. Sci. 63: 187-194. http://dx.doi.org/10.4103/0019-5359.53164 PMid:19584489   Corder GW and Foreman DI (2009). Nonparametric Statistics for Non-Statisticians: A Step-by-Step Approach. Wiley, New York. http://dx.doi.org/10.1002/9781118165881   da Silva XG, Loder MK, McDonald A, Tarasov AI, et al. (2009). TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes 58: 894-905. http://dx.doi.org/10.2337/db08-1187 PMid:19168596 PMCid:2661588   Day CP, Grove J, Daly AK, Stewart MW, et al. (1998). Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 41: 430-434. http://dx.doi.org/10.1007/s001250050926 PMid:9562347   DeLuca HF (1984). The Metabolism, Physiology and Function of Vitamin D. In: Vitamin D, Basic and Clinical Aspects (Kumar R, ed.). Nijhoff Publishing, Boston, 259-302.   Donath MY, Storling J, Maedler K and Mandrup-Poulsen T (2003). Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J. Mol. Med. 81: 455-470. http://dx.doi.org/10.1007/s00109-003-0450-y PMid:12879149   Florez JC, Jablonski KA, Bayley N, Pollin TI, et al. (2006). TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 355: 241-250. http://dx.doi.org/10.1056/NEJMoa062418 PMid:16855264 PMCid:1762036   Gao X, Picchi A, Chilian WM and Zhang C (2007). Role of TNF-alpha in type II diabetes-induced endothelial dysfunction. FASEB J. 21: 893-900.   Gonzalez JR, Armengol L, Sole X, Guino E, et al. (2007). SNPassoc: an R package to perform whole genome association studies. Bioinformatics 23: 644-645. http://dx.doi.org/10.1093/bioinformatics/btm025 PMid:17267436   Halsall JA, Osborne JE, Potter L, Pringle JH, et al. (2004). A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibility and prognosis in malignant melanoma. Br. J. Cancer 91: 765-770. PMid:15238985 PMCid:2364794   Hitman GA and Niven MJ (1989). Genes and diabetes mellitus. Br. Med. Bull. 45: 191-205. PMid:2571389   Holick MF (1995). Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone 17: 107S-111S. http://dx.doi.org/10.1016/8756-3282(95)00195-J   Hotamisligil GS (1999). Mechanisms of TNF-alpha-induced insulin resistance. Exp. Clin. Endocrinol. Diabetes 107: 119-125. http://dx.doi.org/10.1055/s-0029-1212086 PMid:10320052   Huizinga MM and Rothman RL (2006). Addressing the diabetes pandemic: a comprehensive approach. Indian J. Med. Res. 124: 481-484. PMid:17213514   Jolliffe I (1982). A note on the use of principal components in regression. J. R. Stat. Soc. Series C (Applied Statistics) 31: 300-303.   Kern PA, Ranganathan S, Li C, Wood L, et al. (2001). Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280: E745-E751. PMid:11287357   Locksley RM, Killeen N and Lenardo MJ (2001). The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501. http://dx.doi.org/10.1016/S0092-8674(01)00237-9   Marquezine GF, Pereira AC, Sousa AG, Mill JG, et al. (2008). TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population. BMC Med. Genet. 9: 106. http://dx.doi.org/10.1186/1471-2350-9-106 PMid:19055834 PMCid:2632659   Mathis D, Vence L and Benoist C (2001). Beta-cell death during progression to diabetes. Nature 414: 792-798. http://dx.doi.org/10.1038/414792a PMid:11742411   McGee S (2002). Simplifying likelihood ratios. J. Gen. Intern. Med. 17: 646-649. http://dx.doi.org/10.1046/j.1525-1497.2002.10750.x PMid:12213147 PMCid:1495095   Moon RT, Kohn AD, De Ferrari GV and Kaykas A (2004). WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5: 691-701. http://dx.doi.org/10.1038/nrg1427 PMid:15372092   Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, et al. (2002). Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 51: 2294-2300. http://dx.doi.org/10.2337/diabetes.51.7.2294 PMid:12086963   Pickup JC, Mattock MB, Chusney GD and Burt D (1997). NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40: 1286-1292. http://dx.doi.org/10.1007/s001250050822 PMid:9389420   Romeo S, Sentinelli F, Capici F, Arca M, et al. (2001). The G-308A variant of the tumor necrosis factor-alpha (TNF-alpha) gene is not associated with obesity, insulin resistance and body fat distribution. BMC Med. Genet. 2: 10. http://dx.doi.org/10.1186/1471-2350-2-10 PMid:11570978 PMCid:56593   Sicree R, Shaw J and Zimmet P (2006). Diabetes and Impaired Glucose Tolerance. In: Diabetes Atlas (Gan D, ed.). International Diabetes Federation, Brussels, 15-103.   Slattery ML, Folsom AR, Wolff R, Herrick J, et al. (2008). Transcription factor 7-like 2 polymorphism and colon cancer. Cancer Epidemiol. Biomarkers Prev. 17: 978-982. http://dx.doi.org/10.1158/1055-9965.EPI-07-2687 PMid:18398040 PMCid:2587179   Stracke H, Lindemann A and Federlin K (1996). A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. Exp. Clin. Endocrinol. Diabetes 104: 311-316. http://dx.doi.org/10.1055/s-0029-1211460 PMid:8886748   Vozarova B, Weyer C, Hanson K, Tataranni PA, et al. (2001). Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes. Res. 9: 414-417. http://dx.doi.org/10.1038/oby.2001.54 PMid:11445664   Vozarova B, Fernandez-Real JM, Knowler WC, Gallart L, et al. (2003). The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum. Genet. 112: 409-413. PMid:12589429   Wild S, Roglic G, Green A, Sicree R, et al. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053. http://dx.doi.org/10.2337/diacare.27.5.1047 PMid:15111519   Wilkin TJ (2001). The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 44: 914-922. http://dx.doi.org/10.1007/s001250100548 PMid:11508279